Therefore, considered the more extensive expression of B7-H4 compared with the PD-L1 in human cancer and the mechanism of B7-H4 regulating tumor development and progression, we suspect that B7-H4 may be used as a potential target for cancer treatment. The gene discussed is VTCN1; the disease is cancer.